Checked
Multiple sclerosis Clinical Trials in South Carolina
Open studies with at least one site in the state
Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.
- Open studies
- 4
- With a site in South Carolina
- Most studies in
- Greenville
- 3 of the studies shown
Studies
4 of 4, recruiting studies first. Cities are where the study lists a South Carolina site.
- A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisRecruitingPhase 3NCT07299019· Zenas BioPharma (USA), LLC
Greenville
- A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisRecruitingPhase 3NCT07067463· Zenas BioPharma (USA), LLC
Greenville
- A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisRecruitingPhase 3NCT07225504· Novartis Pharmaceuticals
Greenville
- Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation ResearchRecruitingPhase 3NCT07623668· Oculis
Charleston
Other brain and nerves studies in South Carolina
Frequently asked questions
- Are there multiple sclerosis clinical trials in South Carolina?
- Yes. 4 multiple sclerosis studies on ClinicalTrials.gov list at least one site in South Carolina and are recruiting, about to recruit or enrolling by invitation, including sites in Greenville, Charleston.
- What does recruiting mean?
- Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
- How do I join a clinical trial?
- Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.
Source: ClinicalTrials.gov, National Library of Medicine · Last updated 10/26/2026